Fly News Breaks for March 12, 2015
VRX, SLXP, ENDP
Mar 12, 2015 | 08:11 EDT
Leerink believes Endo (ENDP) is unlikely to win the acquisition of Salix (SLXP) since Valeant's (VRX) offer is in all cash and Endo's shares sold off on the news, lessening the value of its buyout proposal. The firm says the estimated deal accretion of 15%-20% may not be enough to push up Endo's stock price.
News For ENDP;SLXP;VRX From the Last 2 Days
There are no results for your query ENDP;SLXP;VRX